Despite the primarily poor patient survival when CCR7 or ligands and VEGF were co-expressed in cancers, at least for some colorectal patients, there was discord between a CCR7 ligand and VEGF, where increased CCL19 levels were positively associated with patient survival, which to some extent was linked to decreased VEGF-A expression [118]. The gene discussed is CCL19; the disease is cancer.